gefitinib has been researched along with nsc 664704 in 2 studies
| Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (nsc 664704) | Trials (nsc 664704) | Recent Studies (post-2010) (nsc 664704) |
|---|---|---|---|---|---|
| 5,231 | 566 | 2,919 | 95 | 0 | 50 |
| Protein | Taxonomy | gefitinib (IC50) | nsc 664704 (IC50) |
|---|---|---|---|
| nuclear receptor subfamily 0 group B member 1 | Homo sapiens (human) | 0.8335 | |
| Cyclin-T1 | Homo sapiens (human) | 0.064 | |
| G2/mitotic-specific cyclin-B2 | Homo sapiens (human) | 0.4 | |
| Tyrosine-protein kinase Lck | Homo sapiens (human) | 0.47 | |
| Cyclin-dependent kinase 1 | Homo sapiens (human) | 0.4 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 1.5 | |
| G2/mitotic-specific cyclin-B1 | Homo sapiens (human) | 0.4 | |
| G2/mitotic-specific cyclin-B | Marthasterias glacialis (spiny starfish) | 0.4243 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.064 | |
| Glycogen synthase kinase-3 beta | Rattus norvegicus (Norway rat) | 0.4243 | |
| Cyclin-A2 | Homo sapiens (human) | 0.73 | |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 0.064 | |
| Cyclin-dependent kinase 2 | Homo sapiens (human) | 0.73 | |
| Mitogen-activated protein kinase 1 | Homo sapiens (human) | 9 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.064 | |
| Glycogen synthase kinase-3 alpha | Homo sapiens (human) | 0.023 | |
| Glycogen synthase kinase-3 beta | Homo sapiens (human) | 0.0657 | |
| Cyclin-dependent kinase 9 | Homo sapiens (human) | 0.064 | |
| Cyclin-A1 | Homo sapiens (human) | 0.73 | |
| Cyclin-dependent-like kinase 5 | Homo sapiens (human) | 0.6314 | |
| Cyclin-dependent kinase 5 activator 1 | Homo sapiens (human) | 0.6314 | |
| G2/mitotic-specific cyclin-B3 | Homo sapiens (human) | 0.4 | |
| Cyclin-dependent kinase 1 | Oryzias latipes (Japanese medaka) | 0.4243 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M | 1 |
| Hajduk, PJ; Johnson, EF; Kifle, L; Merta, PJ; Metz, JT; Soni, NB | 1 |
2 other study(ies) available for gefitinib and nsc 664704
| Article | Year |
|---|---|
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases | 2007 |
Navigating the kinome.
Topics: Drug Design; Pharmacogenetics; Protein Kinases; Proteome; Systems Biology | 2011 |